Calcitonin gene-related peptide receptors in rat trigeminal ganglion do not control spinal trigeminal activity

Journal of Neurophysiology

Volumn 108, Issue 2, 2012, Pages 431-440

  Covasala, Oana ^a   Stirn, Sören L ^a   Albrecht, Stephanie ^a   De Col, Roberto ^a   Messlinger, Karl ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Migraine; Nitric oxide; Olcegepant

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; GLYCERYL TRINITRATE; OLCEGEPANT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CAUDATE NUCLEUS; DURA MATER; MALE; MECHANICAL STIMULATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTIVE FIELD; SIGNAL TRANSDUCTION; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

ACTION POTENTIALS; ANIMALS; MALE; NEURONS; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; TRIGEMINAL GANGLION;

EID: 84864009712     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00167.2011     Document Type: Article

References (65)

1. Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 55: 1335-1340, 2000.
2. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J. Calcitonin generelated peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache. Eur J Neurol 8: 173-178, 2001.
3. Bellamy J, Bowen EJ, Russo AF, Durham PL. Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23: 2057-2066, 2006.
4. Bereiter DA. Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat. Neuroscience 77: 863-874, 1997.
5. Bolton S, Butt AM. Cyclic AMP-mediated regulation of the resting membrane potential in myelin-forming oligodendrocytes in the isolated intact rat optic nerve. Exp Neurol 202: 36-43, 2006.
6. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84: 903-934, 2004.
7. Cherkas PS, Huang TY, Pannicke T, Tal M, Reichenbach A, Hanani M. The effects of axotomy on neurons and satellite glial cells in mouse trigeminal ganglion. Pain 110: 290-298, 2004.
8. Connor KM, Shapiro RE, Diener HC, Lucas S, Kost J, Fan X, Fei K, Assaid C, Lines C, Ho TW. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 73: 970-977, 2009.
9. Cottrell GS, Roosterman D, Marvizon JC, Song B, Wick E, Pikios S, Wong H, Berthelier C, Tang Y, Sternini C, Bunnett NW, Grady EF. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 490: 239-255, 2005.
10. DeLeon M, Covenas R, Chadi G, Narvaez JA, Fuxe K, Cintra A. Subpopulations of primary sensory neurons show coexistence of neuropeptides and glucocorticoid receptors in the rat spinal and trigeminal ganglia. Brain Res 636: 338-342, 1994.
11. Dieterle A, Fischer MJ, Link AS, Neuhuber WL, Messlinger K. Increase in CGRP-and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor. Cephalalgia 31: 31-42, 2011.
12. Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache 46, Suppl 1: S3-S8, 2006.
13. Eberhardt M, Neeb L, Vogel EM, Tiegs G, Reuter U, Messlinger K, Fischer MJ. Glyceroltrinitrate facilitates stimulated CGRP release but not gene expression of CGRP or its receptor components in rat trigeminal ganglia. Neuropeptides 43: 483-489, 2009.
14. Edvinsson L. Calcitonin gene-related peptide (CGRP) in cerebrovascular disease. ScientificWorldJournal 2: 1484-1490, 2002.
15. Edvinsson L, Mulder H, Goadsby PJ, Uddman R. Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst 70: 15-22, 1998.
16. Edvinsson L, Nilsson E, Jansen-Olesen I. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 150: 633-640, 2007.
17. Eftekhari S, Edvinsson L. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 12: 112, 2011.
18. Eltorp CT, Jansen-Olesen I, Hansen AJ. Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide. Cephalalgia 20: 838-844, 2000.
19. Fischer MJ, Koulchitsky S, Messlinger K. The nonpeptide calcitonin generelated peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 25: 5877-5883, 2005.
20. Garry MG, Walton LP, Davis MA. Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res 861: 208-219, 2000.
21. Geppetti P, Del Bianco E, Santicioli P, Lippe IT, Maggi CA, Sicuteri F. Release of sensory neuropeptides from dural venous sinuses of guinea pig. Brain Res 510: 58-62, 1990.
22. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28: 183-187, 1990.
23. Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 48: 457-476, 2005.
24. sAHP, by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons. J Neurophysiol 83: 2071-2079, 2000.
25. + channel, Kir4.1, in satellite cells of rat cochlear ganglia. Am J Physiol Cell Physiol 277: C638-C644, 1999.
26. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM. Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 70: 1304-1312, 2007.
27. Horio Y. Potassium channels of glial cells: distribution and function. Jpn J Pharmacol 87: 1-6, 2001.
28. Ichikawa H, Schulz S, Hollt V, Sugimoto T. The somatostatin sst2A receptor in the rat trigeminal ganglion. Neuroscience 120: 807-813, 2003.
29. Jansen-Olesen I, Mortensen A, Edvinsson L. Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia 16: 310-316, 1996.
30. Jenkins DW, Langmead CJ, Parsons AA, Strijbos PJ. Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro. Neurosci Lett 366: 241-244, 2004.
31. Koulchitsky S, Fischer M, Messlinger K. Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalalgia 29: 408-417, 2009.
32. Koulchitsky S, Fischer MJ, De Col R, Schlechtweg PM, Messlinger K. Biphasic response to nitric oxide of spinal trigeminal neurons with meningeal input in rat-possible implications for the pathophysiology of headaches. J Neurophysiol 92: 1320-1328, 2004.
33. Kummer W, Heym C. Correlation of neuronal size and peptide immunoreactivity in the guinea-pig trigeminal ganglion. Cell Tissue Res 245: 657-665, 1986.
34. Kurosawa M, Messlinger K, Pawlak M, Schmidt RF. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114: 1397-1402, 1995.
35. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 22: 54-61, 2002.
36. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K. Calcitonin receptor-like receptor (CLR), receptor activitymodifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507: 1277-1299, 2008.
37. Levy D, Burstein R, Strassman AM. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58: 698-705, 2005.
38. Li J, Vause CV, Durham PL. Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196: 22-32, 2008.
39. Ma W, Chabot JG, Powell KJ, Jhamandas K, Dickerson IM, Quirion R. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience 120: 677-694, 2003.
40. Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR, Lawrence GW, Dolly JO. Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci 29: 4981-4992, 2009.
41. Messlinger K, Hanesch U, Kurosawa M, Pawlak M, Schmidt RF. Calcitonin gene related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can J Physiol Pharmacol 73: 1020-1024, 1995.
42. Mongan LC, Hill MJ, Chen MX, Tate SN, Collins SD, Buckby L, Grubb BD. The distribution of small and intermediate conductance calcium-activated potassium channels in the rat sensory nervous system. Neuroscience 131: 161-175, 2005.
43. O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 8: 2468-2476, 1988.
44. Offenhauser N, Zinck T, Hoffmann J, Schiemann K, Schuh-Hofer S, Rohde W, Arnold G, Dirnagl U, Jansen-Olesen I, Reuter U. CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia 25: 225-236, 2005.
45. Oku R, Satoh M, Fujii N, Otaka A, Yajima H, Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res 403: 350-354, 1987.
46. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350: 1104-1110, 2004.
47. Petersen KA, Birk S, Doods H, Edvinsson L, Olesen J. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol 143: 697-704, 2004.
48. Pinter E, Helyes Z, Szolcsanyi J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112: 440-456, 2006.
49. Roch M, Messlinger K, Kulchitsky V, Tichonovich O, Azev O, Koulchitsky S. Ongoing activity in trigeminal wide-dynamic range neurons is driven from the periphery. Neuroscience 150: 681-691, 2007.
50. Segond von Banchet G, Pastor A, Biskup C, Schlegel C, Benndorf K, Schaible HG. Localization of functional calcitonin gene-related peptide binding sites in a subpopulation of cultured dorsal root ganglion neurons. Neuroscience 110: 131-145, 2002.
51. Sixt ML, Messlinger K, Fischer MJ. Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain 132: 3134-3141, 2009.
52. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142: 1171-1181, 2004.
53. Tajti J, Uddman R, Moller S, Sundler F, Edvinsson L. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76: 176-183, 1999.
54. Takahashi M, Takeda M, Matsumoto S. Somatostatin inhibits tooth-pulpevoked rat cervical dorsal horn neuronal activity. Exp Brain Res 184: 617-622, 2008.
55. Takeda M, Kadoi J, Takahashi M, Nasu M, Matsumoto S. Somatostatin inhibits the excitability of rat small-diameter trigeminal ganglion neurons that innervate nasal mucosa and project to the upper cervical dorsal horn via activation of somatostatin 2a receptor. Neuroscience 148: 744-756, 2007.
56. Takhshid MA, Poyner DR, Chabot JG, Fournier A, Ma W, Zheng WH, Owji AA, Quirion R. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. Br J Pharmacol 148: 459-468, 2006.
57. Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 47: 1008-1023, 2007.
58. Thomsen LL, Olesen J. Nitric oxide in primary headaches. Curr Opin Neurol 14: 315-321, 2001.
59. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58: 561-568, 2005.
60. Van Op den Bosch J, Van Nassauw L, Van Marck E, Timmermans JP. Somatostatin modulates mast cell-induced responses in murine spinal neurons and satellite cells. Am J Physiol Gastrointest Liver Physiol 297: G406-G417, 2009.
61. van Rossum D, Hanisch UK, Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21: 649-678, 1997.
62. Vause CV, Durham PL. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. J Neurochem 110: 811-821, 2009.
63. Villalon CM, Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 124: 309-323, 2009.
64. Wulf-Johansson H, Amrutkar DV, Hay-Schmidt A, Poulsen AN, Klaerke DA, Olesen J, Jansen-Olesen I. Localization of large conductance calciumactivated potassium channels and their effect on calcitonin gene-related peptide release in the rat trigemino-neuronal pathway. Neuroscience 167: 1091-1102, 2010.
65. Yu Y, Lundeberg T, Yu LC. Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats. Regul Pept 103: 23-27, 2002.